Abstract
Disseminated Acanthamoeba infections are almost invariably fatal, with no universally accepted standard for treatment. Reports of acanthamoebiasis in non-human-immunodeficiency-virus infected hosts are rare. We successfully treated a lung transplant patient who had disseminated acanthamoebiasis using a combination of pentamidine, 5-fluorocytosine, itraconazole, and topical chlorhexidine gluconate/ketoconazole cream.
MeSH terms
-
Acanthamoeba*
-
Adult
-
Amebiasis / drug therapy*
-
Animals
-
Anti-Bacterial Agents / therapeutic use
-
Antifungal Agents / therapeutic use
-
Antiprotozoal Agents / therapeutic use
-
Azithromycin / therapeutic use
-
Drug Therapy, Combination
-
Female
-
Humans
-
Itraconazole / therapeutic use
-
Lung Transplantation
-
Pentamidine / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Antifungal Agents
-
Antiprotozoal Agents
-
Itraconazole
-
Pentamidine
-
Azithromycin